NCT05298774

Brief Summary

The purpose of the study is to determine if the myoelectrical measurements made by the G-Tech Wireless Patch System correlate with clinical markers of postoperative recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness. Subsequently the data will be studied to establish which information in the signals is important in determining when to feed patients and possibly discharge them. These pilot prospective, open clinical studies suggests that myoelectrical activity, measured on the abdominal surface with a noninvasive wireless patch system, carries predictive value in determining time to feeding and time to flatus following open abdominal surgery. Having such information in advance of clinical measures could facilitate timely interventions, be it early feeding or delaying feeding as dictated by the patient's unique recovery profile. The G-Tech Wireless Patch System would provide a unique insight into the process allowing for a tailored protocol that could improve patient satisfaction and optimize recovery. The system could also enable feedback on the impact to the overall gastrointestinal myoelectrical activity of medications, particularly opioids, used for pain management that are known to inhibit gastrointestinal function by disrupting the normal recovery patterns of colonic motility.23-25 While it remains to be seen, in addition to predicting time to flatus/bowel movement early on, the ability to continue monitoring the patient may allow one to predict onset of secondary complications, such as wound infections or anastomotic leaks, that are associated with ileus. Similarly, given the wireless noninvasive nature of the system the patients could be discharged home with the patches, whereby they would serve as a remote monitoring tool. This could be particularly useful in cases where the patients may have been discharged early and may be at a high risk for readmission. The system would then send updates/alerts to the care team for management and potentially avoid preventable readmissions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 28, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

August 3, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

2.3 years

First QC Date

March 17, 2022

Results QC Date

July 3, 2025

Last Update Submit

July 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • GI Functional Recovery

    Time to return of flatus or bowel movement after colorectal surgery

    30 days after index surgery

Secondary Outcomes (2)

  • Postoperative Ileus

    30 days after index surgery

  • Readmission With Ileus

    30 days after index surgery

Study Arms (1)

Postoperative recovery with G-tech WPS

EXPERIMENTAL
Device: G-tech WPS

Interventions

G-tech WPS patches applied and activated within 4 hours of surgery

Postoperative recovery with G-tech WPS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willing and able to provide informed consent
  • Eighteen (18) years of age or older
  • Subject is willing and able to follow all study requirements
  • Subject has undergone or will undergo a laparoscopic or open colorectal surgery with resection and anastomosis

You may not qualify if:

  • Subject is pregnant or suspects pregnancy.
  • Known allergy to medical grade adhesive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale New Haven Hospital

New Haven, Connecticut, 06519, United States

Location

MeSH Terms

Conditions

Gastrointestinal DiseasesIleus

Condition Hierarchy (Ancestors)

Digestive System DiseasesIntestinal ObstructionIntestinal Diseases

Limitations and Caveats

The study is limited by a short follow-up duration restricted to in-patient settings and aligning myoelectric readings with clinical symptoms is under-powered.

Results Point of Contact

Title
Dr. Ira Leeds
Organization
Yale University

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2022

First Posted

March 28, 2022

Study Start

June 1, 2022

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

August 3, 2025

Results First Posted

August 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations